Alzchem Group AG Reports Significant EBITDA Growth in H1 2024

Alzchem Group AG, a vertically integrated specialty chemicals supplier, has reported significant earnings growth in the first half of 2024. The company saw its EBITDA rise by 41.2% to EUR 51.9 million, driven by a strong performance in its Specialty Chemicals segment.

Total sales for Alzchem grew by 3.3% to EUR 286.3 million, with the Specialty Chemicals segment recording a 12.5% increase in sales. This uptick helped offset a 11.8% decline in the Basics & Intermediates segment. The half-year result surged by 78.4% to EUR 26.7 million, while free cash flow increased by 64.5% to EUR 51.4 million.

CEO Andreas Niedermaier expressed satisfaction with the company's progress, highlighting achievements in both business operations and climate roadmap implementations. With the release of these strong results, the Management Board has updated its earnings forecast for the full year 2024, predicting a Group EBITDA of over EUR 100 million.